Ισραήλ - Εβραϊκά - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine 5 % - pessary - povidone-iodine - treatment of vaginal infections caused by fungi, trichomonas, bacteria or mixed infections.

Ισραήλ - Εβραϊκά - Ministry of Health

fischer pharmaceuticals ltd - povidone-iodine - התקן תוך נרתיקי - povidone-iodine 5 % - povidone-iodine - povidone-iodine - treatment of vaginal infections caused by fungi, trichomonas, bacteria or mixed infections.

Ισραήλ - Εβραϊκά - Ministry of Health

rekah pharmaceutical industry ltd, israel - povidone-iodine - תמיסה - povidone-iodine 10 g / 100 ml - povidone-iodine - povidone-iodine - an antiseptic rinse for the vagina.

Ισραήλ - Εβραϊκά - Ministry of Health

tradis gat ltd - fidaxomicin - טבליות מצופות פילם - fidaxomicin 200 mg - fidaxomicin

Ισραήλ - Εβραϊκά - Ministry of Health

pollogen ltd. - אחות - the maximus™ system is indicated for use in dermatologic procedures for non-invasive body shaping, skin tightening, reduction of cellulite and treatment of wrinkles using the combination of trilipo™ rf energy and trilipo™ muscle energy.

Ισραήλ - Εβραϊκά - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - לחות לשיער

Ισραήλ - Εβραϊκά - Ministry of Health

ג'ויה מעבדות לקוסמטיקה בעמ - חפיפת שיער

Ισραήλ - Εβραϊκά - Ministry of Health

מדיקל טכנולוג'יקל קו. mtc - רופא - עמוד שידרה

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - alitretinoin - קפסולות רכות - alitretinoin 10 mg - alitretinoin - alitretinoin - for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .

Ισραήλ - Εβραϊκά - Ministry of Health

glaxo smith kline (israel) ltd - alitretinoin - קפסולות רכות - alitretinoin 30 mg - alitretinoin - alitretinoin - for use in adults who have severe chronic hand eczema that is unresponsive to treatment with potent topical corticosteroids .patients in whom the eczema has predominantly hyperkeratotic features are more likely to respond to treatment than in those in whom the eczema predominantly presents as pompholyx .